Crohn's disease

Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
R B Heuschkel, T T MacDonald, G Monteleone, M Bajaj-Elliott, J A Walker Smith, S L F Pender

Gut Jul 2000, 47 (1) 57-62; DOI: 10.1136/gut.47.1.57
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
B von Lampe, B Barthel, S E Coupland, E-O Riecken, S Rosewicz

Gut Jul 2000, 47 (1) 63-73; DOI: 10.1136/gut.47.1.63
411. THE PREVENTION AND TREATMENT OF MURINE COLITIS USING GENE THERAPY WITH ADENOVIRAL VECTORS ENCODING INTERLEUKIN-10
J.O. Lindsay, C.J. Ciesielski, T. Scheinin, F. Brennan, H.J.F. Hodgson

Gut Mar 2001, 48 (suppl 1) A109-A110; DOI: 10.1136/gut.48.suppl_1.A109
16. INFLAMMATORY BOWEL DISEASE IN THE COMMUNITY: DISEASE PROFILE, HEALTHCARE UTILIZATION, IMPACT ON LIFESTYLE AND PRODUCTIVITY
M.A. Asante

Gut Mar 2001, 48 (suppl 1) A5-A6; DOI: 10.1136/gut.48.suppl_1.A5
Symposium: Gut flora in IBD—practical importance 105–107
Gut Apr 2002, 50 (suppl 2) a29-A30; DOI: 10.1136/gut.50.suppl_2.a29
Plenary posters 168–197
Gut Apr 2002, 50 (suppl 2) a47-A55; DOI: 10.1136/gut.50.suppl_2.a47
224. GUIDELINES FOR OSTEOPOROSIS PREVENTION: HOW FAR HAVE WE YET TO GO?
E. Seward, T. Quigley, M. Smith

Gut Mar 2001, 48 (suppl 1) A60; DOI: 10.1136/gut.48.suppl_1.A60
Inflammatory bowel disease posters 258–298
Gut Apr 2002, 50 (suppl 2) a71-A82; DOI: 10.1136/gut.50.suppl_2.a71
271. INCREASED EXPRESSION OF HUMAN β-DEFENSINS (hBD) 1 AND 2 IN H.PYLORI-POSITIVE AND -NEGATIVE GASTRITIS
P. Fedeli, M.J.G. Farthing, G.V. Smith, M. Bajaj-Elliott

Gut Mar 2001, 48 (suppl 1) A72-A77; DOI: 10.1136/gut.48.suppl_1.A72
TPMT in the treatment of Crohn's disease with azathioprine
L Lennard

Gut Aug 2002, 51 (2) 143-146; DOI: 10.1136/gut.51.2.143

Main menu

Crohn's disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Crohn's disease

Pages